tenk.fyi

Quince Therapeutics, Inc.

QNCXNasdaq· Biological Products, (No Diagnostic Substances)

Price History

Revenue

-

Net Income

-$84.0M

47.8% YoY

EPS

$-1.68

28.2% YoY

Cash

$5.8M

6.5% YoY

FY 2025 · As of 2025-12-31

Pro

10-K Year-over-Year Diff

AI-powered analysis of what changed between the last two annual reports — new risks, removed language, strategy shifts.

Upgrade to Pro